SCHEMBL20809980

SCHEMBL20809980

O=C(NCc1cc(-c2ccccc2Cl)no1)c1cccnc1Cl

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.57
▸ HPGD P15428 6/20 0.57
▸ SMN1; SMN2 Q16637 4/20 0.57
▸ LMNA P02545 1/20 0.57
▸ CYP1A2 P05177 5/20 0.52
▸ CYP2C19 P33261 5/20 0.52
▸ CYP3A4 P08684 3/20 0.52
▸ NPC1 O15118 3/20 0.52
▸ CYP2D6 P10635 3/20 0.51
▸ MAPT P10636 3/20 0.49
▸ POLB P06746 2/20 0.49
▸ HTT P42858 2/20 0.46
▸ RECQL P46063 1/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ ADORA2A P29274 2/20 0.44
▸ ADORA1 P30542 2/20 0.44
▸ TSHR P16473 1/20 0.44
▸ CHRNB2 P17787 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20810206 0.89 HPGD (0.55) ALDH1A1HPGDSMN1; SMN2LMNACYP1A2
SCHEMBL20809984 0.89 ALDH1A1 (0.55) ALDH1A1HPGDSMN1; SMN2LMNACYP1A2
SCHEMBL20810175 0.87 CYP2C19 (0.52) ALDH1A1HPGDSMN1; SMN2LMNACYP1A2
SCHEMBL20810215 0.87 POLB (0.52) ALDH1A1HPGDSMN1; SMN2LMNANPC1
SCHEMBL20810216 0.87 ALDH1A1 (0.52) ALDH1A1HPGDSMN1; SMN2LMNACYP1A2
SCHEMBL20810071 0.87 SMN1; SMN2 (0.59) ALDH1A1HPGDSMN1; SMN2LMNACYP1A2
SCHEMBL20810209 0.83 POLB (0.62) ALDH1A1HPGDSMN1; SMN2LMNACYP1A2
SCHEMBL20810036 0.83 CYP1A2 (0.51) ALDH1A1HPGDSMN1; SMN2LMNACYP1A2
SCHEMBL20810214 0.82 SMN1; SMN2 (0.56) ALDH1A1HPGDSMN1; SMN2LMNACYP1A2
SCHEMBL20810063 0.82 SMN1; SMN2 (0.56) ALDH1A1HPGDSMN1; SMN2LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190077777-A1 NICOTINIC ACID DERIVATIVES, THEIR PREPARATION AND THE USE THEREOF XIAMEN INSTITUTE OF RARE EARTH MATERIALS (CN) 2019-03-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190077777-A1 NICOTINIC ACID DERIVATIVES, THEIR PREPARATION AND THE USE THEREOF H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HCAR3, NAPRT ALDH1A1 1755/4885HPGD 478/4885SMN1; SMN2 2249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback